Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Pande Atul

Over the trailing 90 days, Pande Atul (Director at Immunovant, Inc.) traded $448K of stock (net selling $271K) in IMVT, per 12 SEC Form 4 transactions.

Role
Director
Companies
IMVT
Window
Trailing 90 days · 12 transactions · CIK 1643071
Net activity
−$271K ($89K bought · $360K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
IMVTImmunovant, Inc.12$89K$360K−$271K

Transactions (12)

DateSymbolTypeSharesValueDescription
2026-07-24IMVTSell1.5K$60KOpen market or private sale
2026-07-24IMVTBuy1.5K$13KExercise or conversion of derivative security
2026-07-24IMVTSell1.5K$0Exercise or conversion of derivative security
2026-06-26IMVTSell1.5K$0Exercise or conversion of derivative security
2026-06-26IMVTSell1.5K$57KOpen market or private sale
2026-06-26IMVTBuy1.5K$13KExercise or conversion of derivative security
2026-06-15IMVTSell1.5K$51KOpen market or private sale
2026-06-15IMVTSell1.5K$0Exercise or conversion of derivative security
2026-06-15IMVTBuy1.5K$13KExercise or conversion of derivative security
2026-05-20IMVTSell6.0K$192KOpen market or private sale
2026-05-20IMVTSell6.0K$0Exercise or conversion of derivative security
2026-05-20IMVTBuy6.0K$51KExercise or conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Pande's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free